Paper

0

Document

Download

Flag content

0

CMV-Related Hemorrhagic Retinal Vasculitis in a Multiple Myeloma Patient on Daratumumab Therapy: A Case Report

Show More

Authors

Matthaeus Ware,Yasmin Motekalem

Kirill Zaslavsky,Miguel Cruz-Pimentel,Vishal Kukreti,Alexander Kaplan

+4 authors

Journal

Ocular Immunology and Inflammation

Published

Nov 25, 2024

DOI

10.1080/09273948.2024.2432554

Show more

Save

Tip

Document

Download

Flag content

0

Tip

Save

Document

Download

Flag content

Abstract

To report a case of cytomegalovirus (CMV)-related hemorrhagic retinal vasculitis in a patient with multiple myeloma (MM) on daratumumab, a trial cereblon E3 ligase modulatory drug (CELMoD), dexamethasone, and acyclovir, and discuss clinical implications for CMV prophylaxis.

Paper PDF

This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.